Showing 41 - 47 of 47
Persistent link: https://www.econbiz.de/10005516600
In 1995, a National Health Insurance Law (NHIL) was enacted in Israel. It specified a mandatory package of services to be provided by the four competing private non-profit sickness funds, and secured the financing of that provision. This review discusses the main issues associated with financing...
Persistent link: https://www.econbiz.de/10005516631
A sample of 2500 persons from the general population is used to investigate the stated demand for information about optional treatments, the demand for involvement in the treatment decision making, and the relationships between them. The results show that both clinical information and...
Persistent link: https://www.econbiz.de/10005281218
Persistent link: https://www.econbiz.de/10005224706
The current risk adjustment formula distorts the intended competition on good quality care among the sickness funds, and turns it into a competition on profitable members. After 18 years of using incorrect rates, the Israeli risk adjustment rates should be calculated, as is common in other...
Persistent link: https://www.econbiz.de/10011240879
From the mid-1990s several countries have introduced elements of regulated competition in healthcare. The aim of this paper is to identify the most important preconditions for achieving efficiency and affordability under regulated competition in healthcare, and to indicate to what extent these...
Persistent link: https://www.econbiz.de/10010693379
Uncertainty in the decision-making process for reimbursement of health technologies could be reduced if additional information were available. Although methods to evaluate the monetary value of the uncertainty have been previously described, an economic evaluation of alternative methods to...
Persistent link: https://www.econbiz.de/10010634516